Resmed Inc
RMD240.880USD
-2.200-0.91%
Close 12/31, 16:00（ET）Quotes delayed by 15 min
35.15BMarket Cap
24.55P/E TTM
More Details of Resmed Inc Company
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Resmed Inc Info
Ticker SymbolRMD
Company nameResmed Inc
IPO dateJun 01, 1995
CEOFarrell (Michael J)
Number of employees10600
Security typeOrdinary Share
Fiscal year-endJun 01
Address9001 Spectrum Center Blvd
CitySAN DIEGO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code92123
Phone18587462400
Websitehttps://www.resmed.com/
Ticker SymbolRMD
IPO dateJun 01, 1995
CEOFarrell (Michael J)
Company Executives of Resmed Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
79.62K
-1.24%
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.53%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+6.05%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+10.45%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+11.26%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+21.77%
Ms. Nicole Mowad-Nassar
Ms. Nicole Mowad-Nassar
Independent Director
Independent Director
--
--
Mr. John B. Hernandez
Mr. John B. Hernandez
Independent Director
Independent Director
--
--
Mr. Justin M. W. Leong
Mr. Justin M. W. Leong
Chief Product Officer
Chief Product Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
79.62K
-1.24%
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.53%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+6.05%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+10.45%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+11.26%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Devices
2.67B
51.79%
Masks and other
1.84B
35.75%
By RegionUSD
Name
Revenue
Proportion
United States
3.29B
63.84%
Rest of the world
1.86B
36.16%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Devices
2.67B
51.79%
Masks and other
1.84B
35.75%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
13.00%
BlackRock Institutional Trust Company, N.A.
5.92%
State Street Investment Management (US)
4.49%
Geode Capital Management, L.L.C.
2.91%
Walter Scott & Partners Ltd.
1.93%
Other
71.75%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
13.00%
BlackRock Institutional Trust Company, N.A.
5.92%
State Street Investment Management (US)
4.49%
Geode Capital Management, L.L.C.
2.91%
Walter Scott & Partners Ltd.
1.93%
Other
71.75%
Shareholder Types
Shareholders
Proportion
Investment Advisor
38.51%
Investment Advisor/Hedge Fund
19.37%
Pension Fund
2.46%
Research Firm
2.24%
Bank and Trust
1.36%
Sovereign Wealth Fund
0.88%
Hedge Fund
0.77%
Individual Investor
0.51%
Corporation
0.11%
Other
33.78%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1779
95.72M
65.58%
-1.54M
2025Q3
1773
95.81M
65.64%
-3.83M
2025Q2
1772
96.52M
65.83%
-8.52M
2025Q1
1781
97.60M
66.56%
-6.39M
2024Q4
1734
93.56M
63.70%
-7.66M
2024Q3
1652
90.85M
61.90%
-10.07M
2024Q2
1605
89.55M
60.95%
-7.66M
2024Q1
1565
87.15M
59.25%
-8.40M
2023Q4
1535
84.78M
57.62%
-16.98M
2023Q3
1539
92.21M
62.70%
-12.21M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
18.97M
13%
+292.08K
+1.56%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.65M
5.92%
-28.73K
-0.33%
Sep 30, 2025
State Street Investment Management (US)
6.55M
4.49%
-66.69K
-1.01%
Sep 30, 2025
Geode Capital Management, L.L.C.
4.25M
2.91%
+36.54K
+0.87%
Sep 30, 2025
Walter Scott & Partners Ltd.
2.82M
1.93%
-470.65K
-14.32%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
1.19M
0.81%
+669.17K
+129.03%
Jun 30, 2025
Northern Trust Investments, Inc.
1.16M
0.79%
-9.99K
-0.86%
Sep 30, 2025
Invesco Capital Management LLC
1.12M
0.77%
-44.31K
-3.80%
Sep 30, 2025
BlackRock Asset Management Ireland Limited
1.11M
0.76%
-19.66K
-1.74%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
1.07M
0.73%
+46.64K
+4.57%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Langar Global HealthTech ETF
9.06%
First Trust Nasdaq Lux Digi Health Solutions ETF
7.21%
Pacer US Cash Cows Growth ETF
4.31%
iShares U.S. Medical Devices ETF
4.09%
Global X HealthTech ETF
4.02%
ERShares Entrepreneurs ETF
2.49%
Siren DIVCON Dividend Defender ETF
2.22%
SEI Enhanced US Large Cap Quality Factor ETF
1.92%
First Trust Growth Strength ETF
1.83%
First Trust Indxx Medical Devices ETF
1.82%
View more
Langar Global HealthTech ETF
Proportion9.06%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion7.21%
Pacer US Cash Cows Growth ETF
Proportion4.31%
iShares U.S. Medical Devices ETF
Proportion4.09%
Global X HealthTech ETF
Proportion4.02%
ERShares Entrepreneurs ETF
Proportion2.49%
Siren DIVCON Dividend Defender ETF
Proportion2.22%
SEI Enhanced US Large Cap Quality Factor ETF
Proportion1.92%
First Trust Growth Strength ETF
Proportion1.83%
First Trust Indxx Medical Devices ETF
Proportion1.82%
Dividend
A total of
1.32B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 30, 2025
RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 20, 2025 going ex on Feb 13, 2025
Feb 13, 2025
Mar 20, 2025
Feb 13, 2025
Oct 25, 2024
RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Dec 12, 2024 going ex on Nov 07, 2024
Nov 07, 2024
Dec 12, 2024
Nov 07, 2024
Aug 01, 2024
RMD.NB Final Cash Dividend of gross USD 0.53 paid on Sep 19, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 19, 2024
Aug 15, 2024
Apr 25, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Jun 13, 2024 going ex on May 08, 2024
May 09, 2024
Jun 13, 2024
May 08, 2024
Jan 25, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Mar 14, 2024 going ex on Feb 07, 2024
Feb 08, 2024
Mar 14, 2024
Feb 07, 2024
Oct 27, 2023
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Dec 14, 2023 going ex on Nov 08, 2023
Nov 09, 2023
Dec 14, 2023
Nov 08, 2023
Aug 03, 2023
RMD.NB Final Cash Dividend of gross USD 0.48 paid on Sep 21, 2023 going ex on Aug 16, 2023
Aug 17, 2023
Sep 21, 2023
Aug 16, 2023
Apr 28, 2023
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Jun 15, 2023 going ex on May 10, 2023
May 11, 2023
Jun 15, 2023
May 10, 2023
Jan 27, 2023
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Mar 16, 2023 going ex on Feb 08, 2023
Feb 09, 2023
Mar 16, 2023
Feb 08, 2023
Oct 27, 2022
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Dec 15, 2022 going ex on Nov 09, 2022
Nov 10, 2022
Dec 15, 2022
Nov 09, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Resmed Inc?
The top five shareholders of Resmed Inc are:
The Vanguard Group, Inc. holds 18.97M shares, accounting for 13.00% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 8.65M shares, accounting for 5.92% of the total shares.
State Street Investment Management (US) holds 6.55M shares, accounting for 4.49% of the total shares.
Geode Capital Management, L.L.C. holds 4.25M shares, accounting for 2.91% of the total shares.
Walter Scott & Partners Ltd. holds 2.82M shares, accounting for 1.93% of the total shares.
The Vanguard Group, Inc. holds 18.97M shares, accounting for 13.00% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 8.65M shares, accounting for 5.92% of the total shares.
State Street Investment Management (US) holds 6.55M shares, accounting for 4.49% of the total shares.
Geode Capital Management, L.L.C. holds 4.25M shares, accounting for 2.91% of the total shares.
Walter Scott & Partners Ltd. holds 2.82M shares, accounting for 1.93% of the total shares.
What are the top three shareholder types of Resmed Inc?
The top three shareholder types of Resmed Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
How many institutions hold shares of Resmed Inc (RMD)?
As of 2025Q4, 1779 institutions hold shares of Resmed Inc, with a combined market value of approximately 95.72M, accounting for 65.58% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.06%.
What is the biggest source of revenue for Resmed Inc?
In FY2025, the Devices business generated the highest revenue for Resmed Inc, amounting to 2.67B and accounting for 51.79% of total revenue.
